• News
  • CULTURE & ARTS
  • HIGH CUISINE
  • JUICY TV
  • CROWDGROWING
  • English
  • Spanish
Menu
  • News
  • CULTURE & ARTS
  • HIGH CUISINE
  • JUICY TV
  • CROWDGROWING
  • English
  • Spanish
Search
Close
Search
Close
  • News
  • CULTURE & ARTS
  • HIGH CUISINE
  • JUICY TV
  • CROWDGROWING
  • English
  • Spanish
Menu
  • News
  • CULTURE & ARTS
  • HIGH CUISINE
  • JUICY TV
  • CROWDGROWING
  • English
  • Spanish
Cannabis News

Chronic Pain & Marijuana: Scotland at the Forefront

by Anyela Velandia June 28, 2021
by Anyela Velandia June 28, 2021 0 comment
Chronic Pain & Marijuana: Scotland at the Forefront

In 2018, medical cannabis was authorised under UK legislation, allowing doctors to prescribe cannabis-based medications in certain circumstances. These cannabis-based drugs are used to treat a wide range of illnesses, including back pain, arthritis, and anxiety, where patients have already tried standard treatments that failed to fully relieve the symptoms or produced intolerable secondary effects. Data from medical cannabis programs in Europe and the United States suggest that self-reported pain conditions are the reason behind up to 90% of cannabis authorisations.

Fighting Pain Since the 90s

While this scientific field of research was expanding in the 90s, the therapeutic potential for cannabis, alongside prohibition of possession, became a source of legal challenges led by patients in several countries. These efforts ultimately gave rise to compassionate access programs in Holland, Canada, and Israel, which used various regulatory mechanisms to exempt bona fide patients from prosecution for cannabis possession and authorised cannabis cultivation programs to provide access to quality-controlled and standardised cannabis-based products. In the United States, 22 states have passed citizen initiatives and referendums to allow the medical use of cannabis, despite federal resistance and a refusal to remove cannabis from Schedule 1, where marijuana is deemed to have no medical value and to be too dangerous for use even under medical supervision.

Patients vs Pain

It is moving to see that patients’ efforts have become one of the key drivers of cannabinoid pharmaceuticals development and legalization for medical purposes across many parts of the world.

Leading the way in safely prescribing medical cannabis in the UK, Sapphire Medical was the first clinic to be granted approval by the Care Quality Commission (CQC) to operate in England and takes care of thousands of patients. Since the COVID pandemic, Sapphire has been able to provide telemedicine appointments to patients in England and the current approval granted by HIS allows doctors to carry out medical consultations both face-to-face and through telemedicine in Scotland too.

Suzie Marshall, a 48-year-old bank employee, diagnosed with rheumatoid arthritis, became the first patient to receive a consultation at Sapphire Medical Clinic in Stirling, Scotland.

Additionally, Carl Holvey, Sapphire’s chief pharmacist, states that, in the case of chronic pain, there is “good clinical evidence” to show cannabis efficacy, but the problem is the cost of this treatment, which is not covered by the NHS.

“We are working to gather real-world evidence and clinical data to support the use of these medicines. Hopefully, the data will be used by the authorities to develop the knowledge base to show these medicines are effective—and cost-effective—so they can be used on the NHS,” Holvey claimed.

Chronic PainHealthMedical UseNHSScotland
0 comment
0
FacebookTwitterPinterestEmail
Anyela Velandia

Journalist, host, and radio producer. Colombian peasant by birth and city-dweller by choice. A resident of the City of Buenos Aires, Argentina. In the process of professional and personal training. Prolific and energetic in the face of adversity. Cultural manager of musical groups, artists, and events.

previous post
Rape “Sous Weed”, Espuma de Albahaca y Menta, Bolas de Melón y Tomates Asados, Rúcula
next post
Male, Female, or Hermaphrodite: How to Tell the Sex of a Cannabis Plant

Related Posts

Global Marijuana March in Argentina

May 12, 2022

War Refugees and Cannabis: The Drama of Fleeing

May 9, 2022

Colorado Launches Pilot Grant for Cannabis Cultivation

April 19, 2022

Sierra Cultiva: The First Argentine Growers’ Meeting in...

April 13, 2022

Costa Rica Passed Medical Cannabis and Hemp Regulation...

April 12, 2022

City Council of Milan Asks for Complete Cannabis...

April 4, 2022

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

two × 2 =

Popular Posts

  • 1

    Juicy Update #3: Juicy Coworking Party & Payments out

    July 28, 2020
  • 2

    JuicyFields Transplants its Digital Platform to Amsterdam and Creates New Opportunities to the Crowdgrowing Business

    January 24, 2022
  • 3

    Differences Between Crowdgrowing and Investing in Cannabis

    September 8, 2021
  • 4

    Industrial Hemp Growing in Latin America: A Sustainable Alternative

    May 5, 2021
  • 5

    Evidence Discovered of Medicinal Marijuana in Ancient Egypt

    April 19, 2021
  • 6

    Colombian Cannabis Laws Launch its Legal Marijuana Industry

    April 12, 2021
  • 7

    Costa Rica’s Developing Marijuana Industry

    January 21, 2021
  • 8

    A Recreational Marijuana Program is Underway in Switzerland

    April 14, 2021
  • 9

    Celebrating the Harvest with Cannabis….and Pumpkin Bongs

    November 26, 2020

Recent Posts

  • Juicy Update #3: Juicy Coworking Party & Payments out

    July 28, 2020
  • CBD Infused Savory Rhubarb Tart with Goat Cheese

    May 13, 2022
  • Global Marijuana March in Argentina

    May 12, 2022
  • Medical Cannabis and Schizophrenia

    May 10, 2022
   
  • About Us
  • Terms of Use
  • Privacy Policy
  • Write for us
  • Crowdgrowing
Menu
  • About Us
  • Terms of Use
  • Privacy Policy
  • Write for us
  • Crowdgrowing

Powered by JuicyFields.io